Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users: Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users: Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers: Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey.  Matthew Paulson Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Special Report Oklo: The Bottom Is In, and the Upside Potential Is NuclearAuthor: Thomas Hughes. First Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
Oklo Inc. (NYSE: OKLO) faces headwinds — notably no revenue or profits — yet the market appears largely unconcerned. The company's fiscal 2025 (FY2025) progress report and updates indicate it remains on track to meet long-term goals and market expectations. Analyst reactions after the release reinforce that investors are focused on the long-term opportunity rather than current revenue shortfalls. Analysts Focus on Oklo’s Long-Term Opportunity MarketBeat tracked about half a dozen analyst revisions within the first 12 hours after the release: one price-target reduction offset by several affirmations, and no downgrades. A former Pentagon and CIA advisor is flagging April 15 as a critical date for gold investors. He says the U.S. government is set to grant final authorization for mining operations at what he believes is the largest gold deposit in the world. The company behind it trades at just $2 per share and has largely flown under the radar. He believes early investors positioned before the announcement stand to benefit most. View his full analysis and see the details behind this gold play The activity lines up with the broader trend — growing coverage, a steady Moderate Buy consensus, a 58% Buy-side bias and rising price targets. Those price targets are important: consensus implies more than 50% upside versus mid-March lows. Analysts expressed concern about the 2025 results, but remain primarily focused on the long-term opportunity and progress with Nuclear Regulatory Commission licensing. The company recently received its first license — awarded to subsidiary Atomic Alchemy, which handles isotopes. The license permits the receiving, possession, storage, processing, repackaging and distribution of up to two curies of radium-226 (roughly two grams). Two grams isn’t much, and radium-226 is no longer widely used and can be costly to handle. But it serves as a source material for actinium, one of the most expensive elements, used in specialized cancer treatments that can cost roughly $20,000 per dose. The investor takeaway: Oklo’s diversification strategy has been validated and a revenue stream has been opened. It may take a few quarters for meaningful revenue to appear, but this income could materialize well before the full commercialization of its core nuclear reactor technologies. Institutional and Short-Selling Data Suggest the Bottom Is In Institutional and short-interest data point to a market bottom for Oklo stock. Short interest remains elevated — near 15% as of early March — but it has declined from its peak (which occurred around the company’s October 2025 highs) and is likely to fall further in upcoming reports. Institutional ownership moved the opposite way: it ramped up after Oklo’s Q2 2025 decline and reached record levels in early 2026.  Institutional holders now own roughly 85% of the stock, providing solid support, and are accumulating at an estimated pace of about $3 bought for every $1 sold. If these trends continue, the float available to the market will shrink, making upward price moves more likely. A catalytic news event could also trigger a short squeeze. Dilutive Headwinds Ease in 2026 Shareholder dilution was a meaningful issue in 2025; the company’s share count is up about 50% year-over-year. That said, the balance sheet is well capitalized. FY2026 guidance suggests there is sufficient capital to fund the current project burn rate for roughly two years, which should give secondary revenue streams like the isotope business time to develop. The trade-off is that profitability isn’t expected until around 2030, so additional capital raises may be necessary later. The technical setup is encouraging. OKLO’s stock is well off its highs and appears oversold at March levels. The MACD has turned bullish and the stochastic oscillator has followed, signaling a strong buy at current levels. Whether the market follows through on those signals will take time and depends on execution and headlines — the absence of revenue and profits remains a heavy burden to overcome. The biggest risk is execution and delay. The market is pricing in robust long-term growth — valuing the stock at over 100x initial-year earnings — and may be unforgiving if projects slip. That possibility leaves Oklo exposed to volatility regardless of the timing of a broader rebound. |